These results demonstrate that the PERK-eIF2α-CHOP branch of UPR in neurons plays an important role in autoimmune-induced neurodegeneration, and that combined inhibition of this pathway and activation of the XBP-1 pathway is a promising therapeutic approach for MS. The gene discussed is EIF2AK3; the disease is myeloid sarcoma.